GPT Healthcare Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 24 May 2026 | Healthcare Services | Market Cap: ₹1.3K Cr
Overall revenue growth expected at around 15% year-on-year for FY27 and FY28. - Mature hospitals (Salt Lake, Dum Dum, Agartala, Howrah) targeting occupancy improvements: - Salt Lake aiming for 70%-73% occupancy. - Dum Dum targeting around 72%-73% occupancy. - Agartala expected to reach 58%-60% occupancy, with Bangladesh patient contribution rising back to ~10%. - Howrah projected to achieve late 50% to 60% occupancy. - Raipur hospital targeting 30% occupancy by end of FY27 and expecting to breakeven by Q3 FY27. - Jamshedpur hospital expected to add approx. FY27 revenue expected to grow by approximately 15% year-on-year.
From GPT Healthcare Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹151
Market Cap
₹1.3K Cr
P/E Ratio
27.1
How does GPT Healthcare Ltd rank in Healthcare Services?
Compare GPT Healthcare Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
GPT Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹126 Cr, net profit ₹15 Cr.
Full financials →📊 Revenue & Sales Performance
- →Overall revenue growth expected at around 15% year-on-year for FY27 and FY28.
- →Mature hospitals (Salt Lake, Dum Dum, Agartala, Howrah) targeting occupancy improvements:
- → - Salt Lake aiming for 70%-73% occupancy.
- → - Dum Dum targeting around 72%-73% occupancy.
- → - Agartala expected to reach 58%-60% occupancy, with Bangladesh patient contribution rising back to ~10%.
- → - Howrah projected to achieve late 50% to 60% occupancy.
- →Raipur hospital targeting 30% occupancy by end of FY27 and expecting to breakeven by Q3 FY27.
- →Jamshedpur hospital expected to add approx. 150 beds, with occupancy ramp-up similar to Raipur (~10%-14% in the first year).
- →ARPOB (Average Revenue Per Occupied Bed) expected to grow by about 7%-8% due to tariff increases and product optimization.
- →Anticipated 100 basis points increase in EBITDA margin, aiming around 20.2% EBITDA margin overall.
📈 Profitability & Margins
- →FY27 revenue expected to grow by approximately 15% year-on-year.
- →EBITDA margin anticipated to increase by around 100 basis points, targeting ~20.2%.
- →Raipur hospital expected to break even on a monthly basis by Q3 FY27.
- →ARPOB (Average Revenue Per Occupied Bed) forecasted to grow by 7-8% due to tariff increases and specialty optimization.
- →Occupancies expected to improve: Salt Lake around 70-73%, Dumdum ~72%, Agartala targeting 60%, Howrah late 50s to 60% by Q1 FY28, Raipur reaching 30% by Q4 FY27.
- →Jamshedpur hospital ramp-up expected to mirror Raipur with occupancy of ~10-14% in the first year.
- →Overall positive outlook on operating leverage improvement and sustainable profitability growth amid expanding geographic footprint and optimized specialty mix.
🏗️ Capital Expenditure Plans
- →Jamshedpur Hospital: Major capex to be deployed in FY27, approximately 90% of the total capex incurred in this financial year; remaining 10% mainly creditors-related.
- →Capex per bed for Jamshedpur: Around INR 70 lakhs per bed, similar to Raipur hospital.
- →Bed Addition: Targeting to add around 150 beds through Jamshedpur hospital commission by Q4 FY27.
- →M&A Strategy: Constantly evaluating suitable M&A opportunities in Eastern India, especially for hospitals around 150 to 200 beds. Focus on good real estate assets; no limitation on bed strength, but preference for mid-sized hospitals.
- →Overall Strategy: Evaluating both greenfield and acquisition opportunities post-Jamshedpur to expand portfolio.
- →Raipur: Commissioned in FY26, breakeven expected by Q3 FY27 with ramp-up in occupancy and insurance empanelments expected to improve.
💰 Fundraising & Capital Structure
- →No explicit mention of any new fundraising through debt or equity in the Q4 FY26 earnings call transcript.
- →The management discussed capital expenditure plans, particularly on Jamshedpur hospital, with ~90% capex expected in FY27 and minimal carryover for next year.
- →They emphasized disciplined capital allocation and are focused on improving operational performance and sustainable growth.
- →Management is actively evaluating M&A opportunities, especially for hospitals around 150-200 beds, but no details on raising funds for these.
- →No reference to plans for equity issuance or new debt for expansion or refinancing was provided in the discussed sections.
- →Overall, the company appears to be funding growth primarily through internal accruals and existing financial resources.
📋 Order Book & Pipeline
Key Metrics
Continue your research
What GPT Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
- Health X Platform (Q4 FY26)
Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…
- Park Medi World (Q4 FY26)
Total planned capex for the next two years is around INR 500 crores. Key concall takeaways from Park Medi World's Q4 FY26 earnings call — and how it ranks…
- Vimta Labs (Q4 FY26)
. Key concall takeaways from Vimta Labs Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were GPT Healthcare Ltd Q4 FY26 results?
Overall revenue growth expected at around 15% year-on-year for FY27 and FY28. - Mature hospitals (Salt Lake, Dum Dum, Agartala, Howrah) targeting occupancy improvements: - Salt Lake aiming for 70%-73% occupancy. - Dum Dum targeting around 72%-73% occupancy. - Agartala expected to reach 58%-60% occupancy, with Bangladesh patient contribution rising back to ~10%. - Howrah projected to achieve late 50% to 60% occupancy. - Raipur hospital targeting 30% occupancy by end of FY27 and expecting to breakeven by Q3 FY27. - Jamshedpur hospital expected to add approx. FY27 revenue expected to grow by approximately 15% year-on-year.
What is GPT Healthcare Ltd share price analysis?
GPT Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.
Is GPT Healthcare Ltd planning capital expenditure?
Jamshedpur Hospital: Major capex to be deployed in FY27, approximately 90% of the total capex incurred in this financial year; remaining 10% mainly creditors-related.
Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.